Identifying the molecular mechanisms underlying OL development is not only critical to furthering our knowledge of OL biology, but also has implications for understanding the pathogenesis of demyelinating diseases such as Multiple Sclerosis (MS). Cellular development is commonly studied with primary cell culture models. Primary cell culture facilitates the evaluation of a given cell type by providing a controlled environment, free of the extraneous variables that are present in vivo. While OL cultures derived from rats have provided a vast amount of insight into OL biology, similar efforts at establishing OL cultures from mice has been met with major obstacles. Developing methods to culture murine primary OLs is imperative in order to take advantage of the available transgenic mouse lines.
While exploring the mechanisms of OL development in a purified culture is informative, it does not provide the most physiologically relevant environment for assessing myelin sheath formation. Co-culturing OLs with neurons would lend insight into the molecular underpinnings regulating OL-mediated myelination of axons. For many OL/neuron co-culture studies, dorsal root ganglion neurons (DRGNs) have proven to be the neuron type of choice. They are ideal for co-culture with OLs due to their ease of extraction, minimal amount of contaminating cells, and formation of dense neurite beds. While studies using rat/mouse myelinating xenocultures have been published [4] [5] [6] , a method for the derivation of such OL/DRGN myelinating co-cultures from post-natal murine tissue has not been described. Here we present detailed methods on how to effectively produce such cultures, along with examples of expected results. These methods are useful for addressing questions relevant to OL development/myelinating function, and are useful tools in the field of neuroscience.
Video Link
The video component of this article can be found at http://www.jove.com/video/3324/
Protocol

Ethics Statement
The mice used in this work were cared for according to Canadian Council on Animal Care (CCAC) guidelines. Ethical approval for experiments conducted was obtained from the University of Ottawa Animal Care Committee under protocol number OGH-119.
Dissociation of neonatal cortices and maintenance of mixed glial cultures
Note: The introduction of bubbles into the cell suspension should be avoided during all of the following steps.
1. Add the 15 mL conical tube containing the freshly dissected brains to a 37°C water bath for 3 min. 2. Transfer brains to a sterile tissue culture hood. 3. Gently pass diced cortices through a P1000 pipette tip to generate smaller fragments. Stop pipetting once there are no brain pieces large enough to disrupt a smooth flow of suspension through the pipette tip. 4. Add 75 μL of OPC papain solution per brain into the conical tube. The OPC papain solution must be pre-warmed at 37°C for 20 min prior to use. 5. Incubate in a 37°C water bath for 20 min. Approximately every 2 minutes, gently invert the tube to prevent tissue aggregation. During this time, add 5 mL of mixed glial culture media to each poly-L-lysine (PLL) coated (1 mg/mL) T25 flask (one flask per mouse brain), and place in a 37°C tissue culture incubator at 8.5% CO 2 . 6. After 20 min, return the tissue suspension to the sterile hood and add 2 mL of mixed glial culture media per brain to the tube. Let sit for 10 min at room temperature to allow inactivation of the OPC papain solution. 7. Aliquot the tissue suspension into 5 mL plastic tubes. The number of tubes should match the number of brains dissected, resulting in approximately 2.5 mL per tube. 8. Using a sterile flame-polished glass Pasteur pipette, gently triturate the tissue in each tube. Triturate slowly at first, and gradually increase speed as pieces dissociate. Triturate approximately 10-15 times, however this number may vary based on the efficacy of the digestion.
Note: Under-trituration will result in poor dissociation of the tissue, whereas over-trituration will negatively impact on cell viability. It is important to not introduce bubbles into the solution, as this will severely impact cell viability.
9. Once there are no visible tissue clumps remaining in the suspension, transfer to a 50 mL conical tube containing 4 mL of mixed glial culture media per brain (i.e., 4 brains = 16 mL mixed glial culture media). 10. Gently invert the 50 mL conical tube and repeat for the remaining 5 mL tubes. 11. Aliquot the pooled cell suspension into 15 mL conical tubes (approximately 6.5 mL per 15 mL tube). The number of 15 mL tubes should match the number of brains dissected. 12. Centrifuge the tubes at 1200 rpm (~300 g) for 5 min. 13. Carefully aspirate the supernatant and add 1 mL of warm mixed glial culture media to each 15 mL conical tube. 14. Slowly resuspend the pellet with a P1000 pipette tip, being careful not to introduce bubbles. Add the cell suspension from each tube to a preequilibrated PLL-coated T25 flask, rendering the total volume of the culture media to 6 mL. 15. Place the flasks in a tissue culture incubator for 3-4 hours to allow the cells to attach to the PLL substrate. Perform a full media change by pipetting out the media, and adding 6 mL of fresh mixed glial culture media to the flasks. This step removes much of the debris caused by the trituration, and promotes culture viability. If OL/DRGN co-cultures are desired, refer to Section 3 of this protocol. 16. After 3 days of culture, perform a 2/3 media change by removing 4 mL of media, and replacing with 4 mL of fresh mixed glial culture media.
At this point, an astrocyte monolayer should be forming on the base of the flasks. 17. On Day 6, perform another 2/3 media change and supplement the flasks with a final concentration of 5 μg/mL insulin. At this point, an astrocyte monolayer should be clearly visible, on top of which OPCs will be proliferating.
DRGN isolation
Note: To produce OL/DRGNs co-cultures, DRGNs should be established the day after mixed glial culture generation. Both culture types are grown independently, and combined after 9-10 days.
1. Sacrifice P5-P10 mouse according to institutional guidelines. 2. Extract the spine, and transfer to a clean Petri dish. 3. Trim away as much muscle and bone from the spine as possible (Fig 1d, d '), as this will ease the dissection of the dorsal root ganglia (DRGs). 4. Transfer the trimmed spine to a new Petri dish ventral side-up. Using dissection scissors and starting caudally, cut medially through the spinal column in a longitudinal fashion. 5. Using two pairs of forceps, gently pry open the spinal column to expose the spinal cord. 6. DRGs can be found beneath and lateral to the spinal cord. Using fine tipped forceps, gently remove the DRGs while avoiding damage to the ganglia (Fig 1e) . 7. Transfer the removed DRGs to ice cold Hank's buffered salt solution (HBSS, antibiotic-free) in a new Petri dish. The dissector should aim to extract 40 DRGs per mouse (Fig 1f) . 8. Once the DRGs have been extracted, trim the DRGs of any excessively long roots (Fig 1g, g' ) to minimize introduction of contaminating cells into the culture (glial cells, fibroblasts). 9. Transfer the DRGs to a 1.5 mL centrifuge tube containing 500 μL of ice cold HBSS. 10. Centrifuge at 1200 rpm (~300 g) for 5 min at 4°C to pellet the DRGs. 
Purification of OPCs from mixed glial cultures for establishment of OL-enriched cultures or OL/DRGN co-cultures
1. On Day 9 of the mixed glial culture, transfer the flasks to an orbital shaker in a 5% CO 2 tissue culture incubator. Place the flasks on top of empty T25 flasks to prevent any heat generated from the orbital shaker from adversely affecting the mixed glial cultures. Allow the cultures to equilibrate to this new incubator for 1 hour. 2. Once the flasks have equilibrated, shake the flasks at 50 rpm for 45 min. The purpose of this shake is to remove any loosely adherent contaminating cells from the monolayer. 3. Move cells to a tissue culture hood and remove all the media from the flasks. Replace with 4 mL of fresh mixed glial culture media supplemented with 5 μg/mL insulin. 4. Place the flasks back onto the shaker, and allow to equilibrate for approximately 3 hours. 5. Once the flasks are equilibrated, fasten them securely to the orbital shaker, and shake the flasks for approximately 16 hours at 220 rpm (overnight). 6. The next morning, if OLs are to be grown in the absence of DRGNs (i.e., OL-enriched culture), coat several sterile 12 mm coverslips with LN2 (10 μg/mL in PBS) for 1 hour. Transfer the coverslips to 24-well dishes, wash with PBS followed by an OL media wash. Add 1 mL of OL media to each well and equilibrate at 8.5% CO 2 . 7. Equilibrate 10 cm tissue culture dishes at 5% CO 2 for 30 min. One dish will be required for every 2 flasks. These will be used for the differential adhesion-enrichment of the suspended OPCs. 8. Once the 30 min equilibration period has passed, transfer the media from the shaken flasks to the dishes. Each dish should receive media from 2 flasks, equaling approximately 8 mL of cell suspension per 10 cm dish. 9. Incubate the dishes at 5% CO 2 for 30 min, while providing a gentle nudge at the 15 min mark. This nudge will help prevent OPCs from adhering to the 10 cm dish. 10. Once the incubation is complete, examine the dishes under bright field. OPCs are identified as small cell clumps, typically of 3-5 cells but sometimes form large aggregates resembling neurospheres. Many non-OL lineage cells should be firmly adhered to the base of the plate. Gently swirl the plates to detach any loosely adhered OPCs, and transfer the cell suspension from each plate into a 15 mL conical tube. 11. Centrifuge at 1200 rpm (~300 g) for 5 min. 12. Resuspend the pellet in 1 mL of OL media with a P1000 pipette tip, followed by resuspension with a P200 pipette tip. 13. Count the cells using a hemocytometer. 14. For enriched-OL cultures, seed 25,000 -50,000 OPCs to each 12 mm LN2-coated coverslip in a final volume of 1 mL OL media. 15. For OL/DRGN co-cultures, perform a full OL media (minus CNTF) change on the DRGNs from section [3] , and gently add 50,000 cells from the OPC-enriched cell suspension. Take care to not disrupt the DRGN neurite bed during the addition of OPCs.
Representative Results:
In this protocol, OPCs are expanded on an astrocyte monolayer within a mixed glial culture. This mixed glial culture is derived from P0-P2 neonatal mouse cortex. At day 1 in vitro (DIV1), the mixed glial culture contains cells with varying morphologies as seen by phase contrast microscopy (Fig 2a) . At DIV3, an astrocyte monolayer begins to form on the base of the flask, and at DIV8, OPCs can be clearly observed on the monolayer surface. At DIV9, the proliferating OPCs have reached sufficient density to be purified by overnight high-speed orbital shaking. Once the purification process has been completed, the result is an OPC-enriched cell population. At DIV1-post purification, OPCs have simple morphology, extending few processes (Fig 2b) . At DIV3 post purification, cells have extended a complex meshwork of processes, reminiscent of immature OLs. At DIV6 post purification, the purified OLs have flattened and projected leaflet-like membrane structures. This morphological development is typical of the in vitro maturation of OLs.
Immunofluorescence microscopy indicates the purified cells are of OL-lineage (Fig 3a) . Seeded OPCs initially express chondroitin sulfate proteoglycan (NG2), and develop into myelin-associated glycoprotein (MAG) positive immature OLs within three days post seeding (Fig 3b) . At DIV6, many OLs express myelin basic protein (MBP), and possess typical mature OL morphology. Percent OL-lineage cells were quantified at different time points to determine the purity of the OL-enriched cultures (Fig 3c) . While of great value, the establishment of such cultures is technically challenging. In particular, demanding aspects include efficient tissue digestion/dissociation, maintenance of balanced culture media pH, and DRGN media changes. It is important to consider that the length of digestion, amount of tissue being digested and the amount of trituration affects the efficacy and end result of the tissue dissociation. It is not unusual for experienced researchers to obtain low cellular yields from dissociated nervous system tissues. In addition, murine OPCs tend to be sensitive to changes in the pH of the culture media, particularly under alkaline conditions. The maintenance of cultures at 8.5% CO 2 aims to prevent this, since OPCs appear to better tolerate slightly acidic conditions over basic. With regards to feeding DRGNs, media changes must be performed quickly as to not desiccate the neurons, however, must be gentle as to not disrupt the developing neurite bed. Abrupt media changes may dislodge the neurite bed from the substrate, and likely result in its complete dissociation from the coverslip.
The potential merit of this model system greatly overshadows its technically demanding nature. One advantage of this system is the use of post-natal mice for cell culture derivation, circumventing the need to sacrifice breeding females to harvest embryonic tissue. Another advantage is the lack of requirement for growth factors (GFs) for the expansion of OPCs. Mixed glial cultures provide an environment that supports the propagation of OPCs, presumably due to the presence of astrocyte-derived trophic factors. Other methods, such as derivation via neurospheres 7, 8 , rely on the mitogenic properties of GFs such as basic fibroblast growth factor (bFGF), epidermal growth factor (EGF) and platelet-derived growth factor (PDGF) for OPC expansion. Similarly, using postnatal (P5-10) mice for DRGNs avoids the requirement of supplementing the culture media with nerve growth factor (NGF), a neurotrophic factor required for the in vitro survival of embryonic DRGNs 9, 10 . It is of interest to avoid using NGF as it negatively influences the myelinating capacity of OLs when cultured with DRGNs 4 . Avoiding the use of GF-supplemented media also has economic benefits, as these reagents become costly when used on large scale.
Perhaps the most important benefit of this culture model is its derivation from mouse-only tissues, thus providing the opportunities to derive both OPCs and DRGNs from the wide variety of transgenic mouse lines. This allows for the study of both DRGN and/or OPC-specific properties that govern myelination. This will be especially important for elucidating the receptor/ligand interactions regulating OL-mediated myelination of axons. In all, this technique is of great value with regards to neuroscience research due to its applications towards understanding the molecular cues underlying myelination.
Disclosures
No conflicts of interest declared.
